All In Biotech

Drug Trial Radar · NCT00749450

Combination Chemotherapy After Surgery in Treating Patients With High-Risk Stage II or Stage III Colorectal Cancer

Short Course Oncology Therapy - A Study of Adjuvant Chemotherapy in Colorectal Cancer

Last checked: Nov 19, 2026Latest source record: Jul 27, 2018 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 6,088 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

6,088

Actual

Start

Mar 2008

Primary completion

Nov 2017

Sponsor

Lead sponsor
Cancer Research UK, GlasgowAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Sep 9, 2008

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 120 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

RATIONALE: Drugs used in chemotherapy, such as oxaliplatin, fluorouracil, and capecitabine, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. It is not yet known which combination chemotherapy regimen is more effective in treating patients who have undergone surgery for high-risk colorectal cancer. PURPOSE: This randomized phase III trial is studying chemotherapy given after surgery in treating patients with high-risk stage II or stage III colorectal cancer.

Conditions

  • Colorectal Cancer

Interventions

  • capecitabineDrug

    Given orally

  • fluorouracilDrug

    Given IV

  • oxaliplatinDrug

    Given IV

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. 3-year disease-free survivalTime frame: 3 years

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Beatson West of Scotland Cancer Centre

    Glasgow, Scotland, United Kingdom

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.